These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4807573)

  • 21. [On the effectivity in vitro of heterologous rabbit antisera against mouse leukemia cells (author's transl)].
    Milleck J
    Arch Geschwulstforsch; 1973; 42(4):274-84. PubMed ID: 4138846
    [No Abstract]   [Full Text] [Related]  

  • 22. Human leukemia antigen. I. Production and characterization of antisera.
    Billing R; Terasaki PI
    J Natl Cancer Inst; 1974 Dec; 53(6):1635-8. PubMed ID: 4612163
    [No Abstract]   [Full Text] [Related]  

  • 23. Cytotoxic immune cells with specificity for defined soluble antigens. V. Interaction of antibody with the cytotoxic effector cells in immune or non-immune mouse spleen cells.
    Schirrmacher V; Rubin B; Pross H
    J Immunol; 1974 Jun; 112(6):2219-26. PubMed ID: 4856907
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison of the effect on allograft response of allogeneic and xenogeneic antisera in mice.
    Hilgert I; Pokorná Z; Kristofová H; Vlachov K
    Folia Biol (Praha); 1974; 20(2):116-24. PubMed ID: 4611803
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotherapy of human leukemia.
    Baker MA; Taub RN
    Mt Sinai J Med; 1972; 39(6):548-65. PubMed ID: 4565179
    [No Abstract]   [Full Text] [Related]  

  • 26. Temperature control of lymphocyte-mediated cytotoxicity in vitro.
    Berke G; Sullivan KA
    Transplant Proc; 1973 Mar; 5(1):421-3. PubMed ID: 4695950
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current and prospective problems in tumor immunology].
    Pitzurra M
    Boll Ist Sieroter Milan; 1971; 50(3):209-20. PubMed ID: 4947785
    [No Abstract]   [Full Text] [Related]  

  • 28. Alteration of the specificity of antitumor antisera by the use of passively administered antibody.
    Ungaro PC; Drake WP; Buchholz DH; Mardiney MR
    Cancer Res; 1972 Jul; 32(7):1521-5. PubMed ID: 5030580
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of pregnancy on the reactions of lymphocytes with cytotoxic antisera.
    Taylor PA; Rachkewich RA; Gare DJ; Falk JA; Shumak KH; Crookston MC
    Transplantation; 1974 Jan; 17(1):142-6. PubMed ID: 4855590
    [No Abstract]   [Full Text] [Related]  

  • 31. Heterologous antisera for human histocompatibility testing.
    Balner H; Gabb BW; Dersjant H; Van Vreeswijk W; Van Leeuwen A; Van Rood JJ
    Transplant Proc; 1971 Jun; 3(2):1088-98. PubMed ID: 4944049
    [No Abstract]   [Full Text] [Related]  

  • 32. Serologic distinction between soluble species-specific and strain-specific transplantation antigens.
    Sachs DH; McKenzie IF; Winn HJ; Russell PS
    Transplant Proc; 1973 Mar; 5(1):477-80. PubMed ID: 4540465
    [No Abstract]   [Full Text] [Related]  

  • 33. Thymocytolytic autoantibodies elicited by immunization of mice with chemically-induced sarcoma and leukemia cells.
    Merino F
    Acta Cient Venez; 1982; 33(5):402-5. PubMed ID: 6985343
    [No Abstract]   [Full Text] [Related]  

  • 34. Antimonocyte serum. Preparation and characterization.
    Gościcka T; Rudnicka W; Walencka M
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):449-57. PubMed ID: 6367698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous release of cytotoxic alloantibody from viable cells sensitized in excess antibody.
    Chang S; Stockert E; Boyse EA; Hämmerling U; Old LJ
    Immunology; 1971 Nov; 21(5):829-38. PubMed ID: 4940171
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The PLL gene and histocompatibility genotype in inbred and random-bred guinea pigs.
    Ellman L; Green I; Benacerraf B
    J Immunol; 1971 Aug; 107(2):382-8. PubMed ID: 5568769
    [No Abstract]   [Full Text] [Related]  

  • 37. The nature of blood-borne cytotoxic cells. I. Cooperation between the white cells of the blood and lymph of sheep in the destruction of xenogeneic tumour cells in vitro.
    Grant CK; Glover DJ; Hall JG; Alexander P
    Transplantation; 1974 Mar; 17(3):254-64. PubMed ID: 4814197
    [No Abstract]   [Full Text] [Related]  

  • 38. A quantitative radioisotopic assay for hemolytic antibody by employing technetium-99m-labeled erythrocytes.
    Barth RF; Singla O
    J Immunol; 1974 Feb; 112(2):756-62. PubMed ID: 4813905
    [No Abstract]   [Full Text] [Related]  

  • 39. Immune response of mice to concanavalin A-coated EL 4 leukemia.
    Martin WJ; Wunderlich JR
    Natl Cancer Inst Monogr; 1972 Dec; 35():295-9. PubMed ID: 4679048
    [No Abstract]   [Full Text] [Related]  

  • 40. Some characteristics of immunoglobulin involved in antibody dependent lymphocyte cytotoxicity.
    MacLennan IC; Harding B
    Br J Cancer Suppl; 1973 Aug; 1():7-10. PubMed ID: 4548356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.